Purpose We determined the reasons for radioiodine thyroid remnant ablation, and the
procedure's necessity based on postsurgical remnant size, in patients with putatively “low …

Objective: The treatment of patients with differentiated thyroid cancer (DTC) was modified in
the last decade towards a more individualized approach according to the risk of recurrence …

Abstract Objective According to the 2015 American Thyroid Association (ATA) guidelines,
thyroid ablation by iodine-131 (I-131) therapy is absolutely recommended only in patients …

Objectives Radioactive iodine (RAI) treatment is often indicated after total thyroidectomy in
differentiated thyroid cancer (DTC). However, its role in biochemical or locoregional …

Purpose The aim of this study was to assess the prognostic factors for treatment efficacy, and
in particular the increase in serum thyroglobulin (Tg) level at the time of the first ablative …

Differentiated thyroid cancer (DTC) is typically an indolent disease with a very low disease-
specific mortality. Although most cases are cured with a combination of surgical resection …

Rosario et al. recently suggested that for patients with low-risk differentiated thyroid
carcinoma (DTC) who have a negative neck ultrasound, negative thyroglobulin antibodies …

Purpose We aimed to develop and validate a simplified, novel quantification method for
radioiodine whole-body scans (WBSs) as a predictor for the treatment response in …

Background Radioiodine (RAI) therapy plays a vital role in the postoperative treatment of
differentiated thyroid cancer (DTC) patients underwent total thyroidectomy (TT). However …

Currently a trend towards Bde-escalating^ the role of adjuvant iodine-131 (131I) in the
treatment of differentiated thyroid cancer can be observed in the community of clinical …